Coronavirus: England offers jabs to over-45s after hitting vaccination target, begins Moderna Inc rolloutProactive Investors • 04/13/21
Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of MedicineBusiness Wire • 04/07/21
NIH Starts Study On Allergic Reactions Risk To Pfizer/BioNTech, Moderna COVID-19 VaccinesBenzinga • 04/07/21
Moderna vaccine introduced weeks early as verdict on AstraZeneca jab awaitedProactive Investors • 04/07/21
Research letter indicates that Moderna's COVID-19 vaccine has efficacy past 6 monthsMarket Watch • 04/06/21
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna's COVID-19 Vaccine and Clinical PortfolioBusiness Wire • 04/06/21
Contract drug maker Catalent to double production of Moderna COVID vaccine: WSJMarket Watch • 04/06/21